Literature DB >> 27408411

Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha.

Ayse Salihoglu1, Tugrul Elverdi1, Ahmet Emre Eskazan1, Deniz Eyice2, Isil Bavunoglu2, Muhlis Cem Ar1, Seniz Ongoren1, Elif Guzel3, Zafer Baslar1, Aydin Tunckale2, Nukhet Tuzuner4, Teoman Soysal1.   

Abstract

Congenital dyserythropoietic anemias are a rare group of inherited anemias characterized by ineffective erythropoiesis and distinct morphological abnormalities in the erythroblasts. Interferon alpha has been shown to be effective in type 1 congenital dyserythropoietic anemia but the optimal duration of therapy is undefined. We present here a 32-years-old female patient diagnosed with type 1 congenital dyserythropoietic anemia precipitated by pregnancy and treated successfully with a short course of interferon alpha resulting in a durable response. A literature search including PubMed database on previously published articles regarding congenital dyserythropoietic anemia type 1 patients treated with interferon is conducted.

Entities:  

Year:  2015        PMID: 27408411      PMCID: PMC4925531          DOI: 10.1007/s12288-015-0600-8

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  23 in total

1.  Congenital dyserythropoietic anemia type I with ringed sideroblasts.

Authors:  T Soysal; E Akun; R Ozaras; H Aki; M Ozturk; N Tuzuner
Journal:  Haematologia (Budap)       Date:  2000

Review 2.  Progress in the congenital dyserythropoietic anemias: juicy but high-hanging fruits?

Authors:  Raffaele Renella
Journal:  Am J Hematol       Date:  2010-12       Impact factor: 10.047

3.  Congenital dyserythropoietic anemia with sideroblasts and ringed forms.

Authors:  Khaled Kamaleddin Mohamed; Abdulatif Alfaraidy
Journal:  Ann Saudi Med       Date:  2002 Sep-Nov       Impact factor: 1.526

4.  Response of CDA type I to alpha-interferon.

Authors:  S N Wickramasinghe
Journal:  Eur J Haematol       Date:  1997-02       Impact factor: 2.997

5.  Interferon alpha is an effective therapy for congenital dyserythropoietic anaemia type I.

Authors:  A Shamseddine; A Taher; H Jaafar; J H Haidar; R Nasr; V Arzoumanian; Z Salem; A Bazarbachi
Journal:  Eur J Haematol       Date:  2000-09       Impact factor: 2.997

Review 6.  Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation.

Authors:  Hermann Heimpel; Volker Anselstetter; Ladislav Chrobak; Jonas Denecke; Beate Einsiedler; Kerstin Gallmeier; Antje Griesshammer; Thorsten Marquardt; Gritta Janka-Schaub; Martina Kron; Elisabeth Kohne
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

7.  Long-term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I.

Authors:  Thierry Lavabre-Bertrand; Jeanne Ramos; Christophe Delfour; Laurent Henry; Isabelle Guiraud; Serge Carillo; André Wagner; Jean Paul Bureau; Pierre Blanc
Journal:  Eur J Haematol       Date:  2004-11       Impact factor: 2.997

8.  Congenital dyserythropoietic anemia, type 1, in a polynesian patient: response to interferon alpha2b.

Authors:  Laurent Roda; Jérôme Pasche; Alain Fournier; Vaea Terorotua; Sunitha N Wickramasinghe; Hannah Tamary; Pierre Olivier Schischmanoff; Gil Tchernia; Jean Delaunay
Journal:  J Pediatr Hematol Oncol       Date:  2002 Aug-Sep       Impact factor: 1.289

9.  The acute haemolytic syndrome in Wilson's disease--a review of 22 patients.

Authors:  J M Walshe
Journal:  QJM       Date:  2013-07-09

10.  Successful Allogeneic Hematopoietic Stem Cell Transplantation of a Patient Suffering from Type II Congenital Dyserythropoietic Anemia A Rare Case Report from Western India.

Authors:  Gaurang Modi; Sandip Shah; Irappa Madabhavi; Harsha Panchal; Apurva Patel; Urmila Uparkar; Asha Anand; Sonia Parikh; Kinnari Patel; Kamlesh Shah; Swaroop Revannasiddaiah
Journal:  Case Rep Hematol       Date:  2015-01-26
View more
  1 in total

1.  Neonatal cholestasis and hepatosplenomegaly caused by congenital dyserythropoietic anemia type 1: A case report.

Authors:  Catalina Jaramillo; Anna K Ermarth; Angelica R Putnam; Mark Deneau
Journal:  World J Hepatol       Date:  2019-05-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.